Penn Medicine Provider
Pathology and Laboratory Medicine
Gabriel C. Caponetti, MD
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP
Call 800-789-7366

About me

  • Associate Professor of Clinical Pathology and Laboratory Medicine

Education and training

  • Medical School: University of Buenos Aires
  • Residency: Baystate Medical Center
  • Fellowship: University of Nebraska Medical Center
  • Fellowship: University of Iowa Hospitals and Clinics

Insurance accepted

My Locations

Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Caponetti is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Bhattacharyya S, Inamdar A, Caponetti GC. Transdifferentiation of Follicular Lymphoma to Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma. , Atlantic Regional Hematopathology Meeting, May 2023, Fox Chase Cancer Center, Philadelphia, PA.: 2023

Singhal S, Azari F, Caponetti GC, Kennedy GT. Novel intraoperative near-infrared imaging strategy to identify abnormalities in the anterior mediastinum. , J Cardiothorac Surg. 2022;17(1):302.: 2022

Quereda Bernabeu B, Caponetti GC. Burkitt Lymphoma with Tetrasomy 1q: A Mature B-cell Lymphoma with Immature Features. , Meeting of the Society for Hematopathology/European Association for Hematopathology. Lymphoma Workshop. 2022. Firenze, Italy.: 2022

Daneshpajouhnejad P Caponetti GC. Diffuse Large B-cell Lymphoma, NOS, with Unusual Association of GCB Immunophenotype and MCD Genotype: The Relevance of Upfront Gene Sequencing on Cases of de Novo Diffuse Large B-cell Lymphoma. , Meeting of the Society for Hematopathology/European Association for Hematopathology. Lymphoma Workshop. 2022. Firenze, Italy.: 2022

Laczko D, Caponetti GC. Splenic Marginal Zone Lymphoma with BIRC3 mutations. , Meeting of the Society for Hematopathology/European Association for Hematopathology. Lymphoma Workshop. 2022. Firenze, Italy.: 2022

Hurwitz S, Caponetti GC. PD1+ T-cell hyperplasia in nodal marginal zone lymphoma. , Meeting of the Society for Hematopathology/European Association for Hematopathology. Lymphoma Workshop. 2022. Firenze, Italy.: 2022

Peter A, Davis A, Caponetti GC, Bagg A. Plasmablastic Lymphoma: De Novo Vs an Unusual Richter Transformation. , Meeting of the Society for Hematopathology/European Association for Hematopathology. Lymphoma Workshop. 2022. Firenze, Italy.: 2022

Landsburg D, Caponetti GC, Bagg A, Schuster S., Nasta S, Gerson J, Frank F, Barta S, Svoboda J, Bhattacharyya S, Qualtieri J, Lim M, Chong E, Roth J, Elenitoba-Johnson K, Priore S, Deihimi S, Morrissette J. Clinical laboratory mutation analysis performed on aggressive B cell non-Hodgkin lymphoma patient biopsies. , J Clin Oncol. 2022. 40:16_suppl, e19561-e19561.: 2022

Laczko D, Caponetti GC. Therapy-related acute myeloid leukemia with inv(16)(p13.1q22); CBF-MYH11. , EBMWG bone marrow course and workshop. 2022. Lund, Sweden.: 2022

Daneshpajouhnejad P, Caponetti GC. A case of de novo acute myeloid leukemia, NOS, with monocytic differentiation and a BRAF V600E mutation. , EBMWG bone marrow course and workshop. 2022. Lund, Sweden.: 2022